Schabacker Matthew bought CNMD
March 2, 2026 · Form 4 insider transaction
Schabacker Matthew bought 9,827 shares of CONMED Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,827
Price
$0.00
Total value
N/A
InsiderSchabacker Matthew
Role—
CompanyCONMED Corporation (CNMD)
SecurityRSUs (Restricted Stock Units)
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after9,827
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.